Virtus ETF Advisers’s Alpine Immune Sciences Inc ALPN Stock Holding History

Virtus ETF Advisers’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,591	Closed	-$182K	–	486
2024 Q1	$182K	Sell	4,591 -313	-6%	-$9.24K	0.1%	275
2023 Q4	$93.5K	Buy	+4,904	New	+$68.1K	0.06%	391

Virtus ETF Advisers's ALPN Position: Q2 2024 in Review

Virtus ETF Advisers sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 4,591 shares — an estimated $182K sold.

Virtus ETF Advisers first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $182K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Virtus ETF Advisers reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Virtus ETF Advisers sold 4,591 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $182K.
Virtus ETF Advisers first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
Virtus ETF Advisers's Alpine Immune Sciences Inc position peaked at $182K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Virtus ETF Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.